AKT3 | | Target | Target | Glutathione S-Transferase Mu 2 | | | | | | |
Lung Carcinoma | | Disease | Target | Aldo-Keto Reductase Family 1 Member C3 | | | | | | |
Glomerulonephritis | | Disease | Target | Glutathione S-Transferase Mu 2 | | | | | | |
Shock | | Disease | Target | Prostaglandin Reductase 1 | | | | | | |
Benign Prostatic Hyperplasia | | Disease | Target | Aldo-Keto Reductase Family 1 Member C3 | | | | | | |
Annexin A1 | | Target | Target | Glutathione S-Transferase Mu 2 | | | | | | |
Major Depressive Disorder | | Disease | Drug | Alprazolam (Xanax)- FDA | | | | | | |
CCL2 | | Target | Target | Glutathione S-Transferase Mu 2 | | | | | | |
Antithrombin | | Target | Target | Glutathione S-Transferase Mu 2 | | | | | | |
Acute Coronary Syndromes | | Disease | Target | Brain (B-type) Natriuretic Protein | | | | | | |
Glutaredoxin-1 | | Target | Target | Glutathione S-Transferase Mu 2 | | | | | | |
Collagen | | Target | Target | Brain (B-type) Natriuretic Protein | | | | | | |
Cardiac Arrest | | Disease | Drug | Doxaminol | | | | | | |
Avandia (Rosiglitazone Maleate)- FDA | | Drug | Drug | Alprazolam (Xanax)- FDA | | | | | | |
Leukemia | | Disease | Target | Exodus-3 | | | | | | |
Breast Cancer | | Disease | Target | Glutathione S-Transferase Mu 2 | | | | | | |
Breast Cancer | | Disease | Target | Exodus-3 | | | | | | |
Proteinuria | | Disease | Target | Glutathione S-Transferase Mu 2 | | | | | | |
CD34 | | Target | Target | Exodus-3 | | | | | | |
Inflammation | | Disease | Target | Exodus-3 | | | | | | |
CCL21 | | Target | Target | Exodus-3 | | | | | | |
CD68 | | Target | Target | Carbonic Anhydrase 4 | | | | | | |
Colon Cancer | | Disease | Drug | Doxorubicin-Formaldehyde Conjugate | | | | | | |
Colon Cancer | | Disease | Drug | Doxoform | | | | | | |
Diabetes | | Disease | Drug | Aprotinin (Trasylol)- FDA | | | | | | |
Diabetes | | Disease | Target | CXCL4/PF4 | | | | | | |
CCL19 | | Target | Target | CXCL4/PF4 | | | | | | |
Obesity | | Disease | Drug | Doxazolidine | | | | | | |
Carcinoma | | Disease | Target | Carbonic Anhydrase 4 | | | | | | |
Carcinoma | | Disease | Target | CXCL4/PF4 | | | | | | |
Hemorrhage | | Disease | Drug | Aprotinin (Trasylol)- FDA | | | | | | |
CXCL7 | | Target | Target | CXCL4/PF4 | | | | | | |
BLyS | | Target | Target | CD254 | | | | | | |
CCL4 | | Target | Target | CXCL4/PF4 | | | | | | |
Prostate Cancer | | Disease | Target | CXCL4/PF4 | | | | | | |
Tuberculosis | | Disease | Target | Carbonic Anhydrase 4 | | | | | | |
Skin Cancer | | Disease | Target | CD254 | | | | | | |
Infection | | Disease | Target | CINC-2- alpha | | | | | | |
Infection | | Disease | Target | CXCL4/PF4 | | | | | | |
Glaucoma | | Disease | Target | Carbonic Anhydrase 4 | | | | | | |
Cathepsin G | | Target | Target | CINC-2- alpha | | | | | | |
Stroke | | Disease | Drug | Aprotinin (Trasylol)- FDA | | | | | | |
Glomerulonephritis | | Disease | Target | CXCL4/PF4 | | | | | | |
Arthritis | | Disease | Target | CD254 | | | | | | |
CD154 | | Target | Target | CD254 | | | | | | |
Sarcoidosis | | Disease | Target | Carbonic Anhydrase 4 | | | | | | |
Rheumatoid Arthritis | | Disease | Target | CD254 | | | | | | |
Retinitis | | Disease | Target | Carbonic Anhydrase 4 | | | | | | |
Collagen | | Target | Target | CXCL4/PF4 | | | | | | |
CD95 | | Target | Target | CD254 | | | | | | |